Erratum: Nanobubble ultrasound contrast agents for enhanced delivery of thermal sensitizer to tumors undergoing radiofrequency ablation (Pharmaceutical Research (2014) DOI: 10.1007/s11095-013-1100-x);Nanobubble ultrasound contrast agents for enhanced delivery of thermal sensitizer to tumors undergoing radiofrequency ablation

Pharmaceutical Research

Volumn 31, Issue 6, 2014, Pages 1407-1417

  Perera, Reshani H ^a   Solorio, Luis ^a   Wu, Hanping ^a   Gangolli, Mihika ^b   Silverman, Eric ^b   Hernandez, Christopher ^a   Peiris, Pubudu M ^a,b   Broome, Ann Marie ^c   Exner, Agata A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Case Western Reserve University   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

colorectal cancer; Pluronic nanobubble; radiofrequency ablation; ultrasound contrast agents

Indexed keywords

1,2 DIPALMITOYL SN GLYCERO 3 PHOSPHATE; 1,2 DIPALMITOYL SN GLYCERO 3 PHOSPHOETHANOLAMINE; DIPALMITOYLPHOSPHATIDYLCHOLINE; ECHO CONTRAST MEDIUM; LIPID; NANOBUBBLE; PLURONIC L 10; POLOXAMER; RADIOSENSITIZING AGENT; UNCLASSIFIED DRUG; CONTRAST MEDIUM; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER THERAPY; CELL VIABILITY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FORMULATION; DRUG STABILITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SENSITIZATION; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR XENOGRAFT; ZETA POTENTIAL; ANIMAL; CATHETER ABLATION; CELL SURVIVAL; CHEMISTRY; DIAGNOSTIC USE; DRUG EFFECTS; DRUG SCREENING; ECHOGRAPHY; MICROBUBBLE; NEOPLASMS; PROCEDURES; TISSUE DISTRIBUTION;

ANIMALS; CATHETER ABLATION; CELL SURVIVAL; CONTRAST MEDIA; DRUG DELIVERY SYSTEMS; HUMANS; MICE; MICROBUBBLES; NANOPARTICLES; NEOPLASMS; TISSUE DISTRIBUTION; ULTRASONOGRAPHY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84902158694     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-014-1327-1     Document Type: Erratum

References (42)

1. Beinfeld MT, Bosch JL, Isaacson KB, Gazelle GS. Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroids. Radiology. 2004;230:207-13.
2. Park IJ, Kim HC, Yu CS, Kim PN, Won HJ, Kim JC. Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery. Ann Surg Oncol. 2008;15:227-32.
3. Zerbini A, Pilli M, Laccabue D, Pelosi G, Molinari A, Negri E, et al. Radiofrequency thermal ablation for hepatocellular carcinoma stimulates autologous NK-cell response. Gastroenterology. 2010;138:1931-42.
4. Wong SL, Mangu PB, Choti MA, Crocenzi TS, Dodd 3rd GD, Dorfman GS, et al. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol. 2010;28:493-508.
5. Kawamura Y, Ikeda K, Seko Y, Hosaka T, Kobayashi M, Saitoh S, et al. Heterogeneous type 4 enhancement of hepatocellular carcinoma on dynamic CT is associated with tumor recurrence after radiofrequency ablation. Ajr. 2011;197:W665-73.
6. Calderwood SK, Ciocca DR. Heat shock proteins: stress proteins with Janus-like properties in cancer. Int J Hyperth. 2008;24:31-9.
7. Wu H, Exner AA, Shi H, Bear J, Haaga JR. Dynamic evolutionary changes in blood flow measured by MDCT in a hepatic VX2 tumor implant over an extended 28-day growth period: time-density curve analysis. Acad Radiol. 2009;16:1483-92.
8. Perera RH, Krupka TM, Wu H, Traughber B, Dremann D, Broome AM, et al. Role of Pluronic block copolymers in modulation of heat shock protein 70 expression. Int J Hyperth. 2011;27:672-81.
9. Kabanov AV, Batrakova EV, Alakhov VY. Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release. 2002;82:189-212.
10. Batrakova EV, Li S, Alakhov VY, Miller DW, Kabanov AV. Optimal structure requirements for pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells. J Pharmacol Exp Ther. 2003;304:845-54.
11. Krupka TM, Exner A. Structural Parameters govering activity of pluronic triblock copolymers in hyperthermia cancer therapy. Int J Hyperthermia. 2011;27(7):663-71.
12. Rapoport N, Pitt WG, Sun H, Nelson JL. Drug delivery in polymeric micelles: from in vitro to in vivo. J Control Release. 2003;91:85-95.
13. Husseini GA, Diaz de la Rosa MA, Gabuji T, Zeng Y, Christensen DA, Pitt WG. Release of doxorubicin from unstabilized and stabilized micelles under the action of ultrasound. J Nanosci Nanotechnol. 2007;7:1028-33.
14. Kabanov AV, Batrakova EV, Alakhov VY. An essential relationship between ATP depletion and chemosensitizing activity of Pluronic block copolymers. J Control Release. 2003;91:75-83.
15. Batrakova EV, Li S, Vinogradov SV, Alakhov VY, Miller DW, Kabanov AV. Mechanism of pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization. J Pharmacol Exp Ther. 2001;299:483-93.
16. Batrakova E, Lee S, Li S, Venne A, Alakhov V, Kabanov A. Fundamental relationships between the composition of pluronic block copolymers and their hypersensitization effect in MDR cancer cells. Pharm Res. 1999;16:1373-9.
17. Batrakova EV, Li S, Brynskikh AM, Sharma AK, Li Y, Boska M, et al. Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers. J Control Release. 2010;143:290-301.
18. Rapoport N, Marin A, Luo Y, Prestwich GD, Muniruzzaman MD. Intracellular uptake and trafficking of Pluronic micelles in drug-sensitive and MDR cells: effect on the intracellular drug localization. J Pharm Sci. 2002;91:157-70.
19. Tranquart F, Mercier L, Frinking P, Gaud E, Arditi M. Perfusion quantification in contrast-enhanced ultrasound (CEUS) - ready for research projects and routine clinical use. Ultraschall Med. 2012;33:S31-38.
20. Claudon M, Dietrich CF, Choi BI, Cosgrove DO, Kudo M, Nolsoe CP, et al. Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol. 2012;39:187-210.
21. Rognin NG, Arditi M, Mercier L, Frinking PJ, Schneider M, Perrenoud G, et al. Tranquart, Parametric imaging for characterizing focal liver lesions in contrast-enhanced ultrasound. IEEE Trans Ultrason Ferroelectr Freq Control. 2010;57(11):2503-11.
22. Hoyt K, Warram JM, Umphrey H, Belt L, Lockhart ME, Robbin ML, et al. Determination of breast cancer response to bevacizumab therapy using contrast-enhanced ultrasound and artificial neural networks. J Ultrasound Med. 2010;29:577-85.
23. Guibal A, Taillade L, Mule S, Comperat E, Badachi Y, Golmard JL, et al. Noninvasive contrast-enhanced US quantitative assessment of tumor microcirculation in a murine model: effect of discontinuing anti-VEGF therapy. Radiology. 2010;254:420-9.
24. Lassau N, Koscielny S, Chami L, Chebil M, Benatsou B, Roche A, et al. Advanced hepatocellular carcinoma: early evaluation of response to bevacizumab therapy at dynamic contrast-enhanced US with quantification - preliminary results. Radiology. 2011;258:291-300.
25. Kamaev P, Rapoport N. Effect of anticancer drug on cell sensitivity to ultrasound in vitro and in vivo. Am J Phys. 2006;829:543-7.
26. Marmottant P, Hilgenfeldt S. Controlled vesicle deformation and lysis by single oscillating bubbles. Nature. 2003;423:153-6.
27. Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, et al. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res. 1995;55:3752-6.
28. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci U S A. 1998;95:4607-12.
29. Andresen TL, Jensen SS, Jorgensen K. Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release. Prog Lipid Res. 2005;44:68-97.
30. Peiris PM, Toy R, Doolittle E, Pansky J, Abramowski A, Tam M, et al. Imaging metastasis using an integrin-targeting chain-shaped nanoparticle. ACS nano. 2012;6(10):8783-95.
31. Krupka TM, Solorio L, Wilson RE, Wu H, Azar N, Exner AA. Formulation and characterization of echogenic lipid-pluronic nanobubbles. Mol Pharm. 2009;7:49-59.
32. Wu H, Rognin N, Krupka T, Yoshiara H, Guenette G, Sanders C, et al. Acoustic characterization and pharamacokinetic analyses of new nanobubble ultrasound contrast agents. Ultrasound Med Biol. 2013; In press.
33. Sakai T, Alexandridis P. Single-step synthesis and stabilization of metal nanoparticles in aqueous pluronic block copolymer solutions at ambient temperature. Langmuir. 2004;20:8426-30.
34. Yin T, Wang P, Zheng R, Zheng B, Cheng D, Zhang X, et al. Nanobubbles for enhanced ultrasound imaging of tumors. Int J Nanomedicine. 2012;7:895-904.
35. Gao Z, Kennedy AM, Christensen DA, Rapoport NY. Drug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy. Ultrasonics. 2008;48:260-70.
36. Euhus DM, Hudd C, LaRegina MC, Johnson FE. Tumor measurement in the nude mouse. J Surg Oncol. 1986;31:229-34.
37. Avwioro G. Histochemical uses of haematoxylin - a review. J Phys Chem Solids. 2011;1:24-34.
38. du Toit LC, Govender T, Pillay V, Choonara YE, Kodama T. Investigating the effect of polymeric approaches on circulation time and physical properties of nanobubbles. Pharm Res. 2011;28:494-504.
39. Samaddar SK, De JN, Sperber D. Realistic estimate of incomplete fusion excitation function in nucleus-nucleus collisions. Phys Rev C Nucl Phys. 1992;46:2631-4.
40. Lentacker I, Geers B, Demeester J, De Smedt SC, Sanders NN. Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: cytotoxicity and mechanisms involved. Mol Ther. 2010;18:101-8.
41. Watson KD, Lai CY, Qin S, Kruse DE, Lin YC, Seo JW, et al. Ultrasound increases nanoparticle delivery by reducing intratumoral pressure and increasing transport in epithelial and epithelial-mesenchymal transition tumors. Cancer Res. 2012;72:1485-93.
42. Rendon RA, Gertner MR, Sherar MD, Asch MR, Kachura JR, Sweet J, et al. Development of a radiofrequency based thermal therapy technique in an in vivo porcine model for the treatment of small renal masses. J Urol. 2001;166:292-8.